Eur Rev Med Pharmacol Sci 2019; 23 (14): 6211-6216

DOI: 10.26355/eurrev_201907_18438

PLCE1 inhibits apoptosis of non-small cell lung cancer via promoting PTEN methylation

Q.-Y. Yue, W. Zhao, Y. Tan, X.-L. Deng, Y.-H. Zhang

Department of Respiratory Medicine, The First People’s Hospital of Yunnan Province, Kunming, China. 32533760@qq.com


OBJECTIVE: To explore the role of phospholipase C epsilon 1 (PLCE1) in regulating cell apoptosis of non-small cell lung cancer (NSCLC) and its underlying mechanism.

PATIENTS AND METHODS: The mRNA and protein levels of PLCE1 in NSCLC tissues, adjacent normal tissues and NSCLC cell lines (A549 and H1299) were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot, respectively. Methylation status in the promoter region of PTEN in NSCLC cells was accessed using the relative commercial kit. Cell apoptosis after transfection of PLCE1 siRNA in NSCLC cells was detected by flow cytometry. Protein expressions of apoptosis-related genes in NSCLC cells after altering PLCE1 expression were detected by Western blot.

RESULTS: PLCE1 was highly expressed in NSCLC tissues and cell lines than that of controls. PLCE1 knockdown promoted PTEN expression and inhibited methylation in H1299 cells. Transfection of PLCE1 siRNA in NSCLC cells remarkably induced cell apoptosis.

CONCLUSIONS: PLCE1 inhibits cell apoptosis of NSCLC by promoting PTEN methylation.

Free PDF Download

To cite this article

Q.-Y. Yue, W. Zhao, Y. Tan, X.-L. Deng, Y.-H. Zhang
PLCE1 inhibits apoptosis of non-small cell lung cancer via promoting PTEN methylation

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 14
Pages: 6211-6216
DOI: 10.26355/eurrev_201907_18438